Legend Biotech (LEGN) Revenue (2019 - 2026)
Legend Biotech's (LEGN) quarterly Revenue came in at $305.1 million in Q1 2026, up 56.46% YoY from $195.0 million in Q1 2025, and little changed on a QoQ basis from $306.3 million in Q4 2025.
Legend Biotech (LEGN) Revenue (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Revenue data on file, last reported at $305.1 million in Q1 2026.
- Quarterly Revenue rose 56.46% year-over-year to $305.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 56.38% YoY) and the FY2025 annual result came in at $1.0 billion, up 64.02% from the prior year.
- Revenue steadied at $305.1 million in Q1 2026, from $306.3 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $79.5 billion in Q4 2023 to a low of $12.0 million in Q2 2022.
- A 5-year average of $4.8 billion and a median of $160.2 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue jumped 287469.21% — and 2024, when it slumped 99.77%.
- Tracing LEGN's Revenue over 5 years: stood at $27.6 million in 2022, then jumped by 287469.21% to $79.5 billion in 2023, then tumbled by 99.77% to $186.5 million in 2024, then soared by 64.24% to $306.3 million in 2025, then declined by 0.39% to $305.1 million in 2026.
- The last three Revenue figures came in at $305.1 million (Q1 2026), $306.3 million (Q4 2025), and $272.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 387.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 387.50 Mn |
| Mar 31, 2026 | 305.10 Mn |
| Dec 31, 2025 | 306.30 Mn |
| Sep 30, 2025 | 272.33 Mn |
| Jun 30, 2025 | 255.06 Mn |
| Mar 31, 2025 | 195.00 Mn |
| Dec 31, 2024 | 186.50 Mn |
| Sep 30, 2024 | 160.21 Mn |
| Jun 30, 2024 | 186.52 Mn |
| Mar 31, 2024 | 93.99 Mn |
| Dec 31, 2023 | 79.46 Bn |
| Sep 30, 2023 | 96.01 Mn |
| Jun 30, 2023 | 73.33 Mn |
| Mar 31, 2023 | 36.34 Mn |
| Dec 31, 2022 | 27.63 Mn |
| Sep 30, 2022 | 27.36 Mn |
| Jun 30, 2022 | 11.97 Mn |
| Mar 31, 2022 | 50.04 Mn |
| Dec 31, 2021 | 39.00 Mn |
| Sep 30, 2021 | 16.88 Mn |